Musculoskeletal phenotypes in 3q29 deletion syndrome
American Journal of Medical Genetics Part A · 2023
DOI: 10.1002/ajmg.a.63384 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Rebecca M Pollak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA. Hauptthemen laut MEDLINE: Developmental Disabilities, Intellectual Disability. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
3q29 deletion syndrome (3q29del) is a rare genomic disorder caused by a 1.6 Mb deletion (hg19, chr3:195725000–197350000). 3q29del is associated with neurodevelopmental and psychiatric phenotypes, including an astonishing >40‐fold increased risk for schizophrenia, but medical phenotypes are less well‐described. We used the online 3q29 registry of 206 individuals ( 3q29deletion.org ) to recruit 57 individuals with 3q29del (56.14% male) and requested information about musculoskeletal phenotypes with a custom questionnaire. 85.96% of participants with 3q29del reported at least one musculoskeletal phenotype. Congenital anomalies were most common (70.18%), with pes planus (40.35%), pectus excavatum (22.81%), and pectus carinatum (5.26%) significantly elevated relative to the pediatric general population. 49.12% of participants reported fatigue after 30 min or less of activity. Bone fractures (8.77%) were significantly elevated relative to the pediatric general population. Participants commonly report receiving medical care for musculoskeletal complaints (71.93%), indicating that these phenotypes impact quality of life for individuals with 3q29del. This is the most comprehensive description of musculoskeletal phenotypes in 3q29del to date, suggests ideas for clinical evaluation, and expands our understanding of the phenotypic spectrum of this syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA.
- Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
- Emeritus Professor of Orthopedic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA.
Förderung
- NIMH NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Pollak, R. M., Tilmon, J. C., Murphy, M. M., Gambello, M. J., Sanchez Russo, R., Dormans, J. P., & Mulle, J. G. (2023). Musculoskeletal phenotypes in 3q29 deletion syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63384
Vancouver
Pollak RM, Tilmon JC, Murphy MM, Gambello MJ, Sanchez Russo R, Dormans JP, et al. Musculoskeletal phenotypes in 3q29 deletion syndrome. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63384
BibTeX
@article{Pollak2023,
author = {Pollak, Rebecca M and Tilmon, Jacob C and Murphy, Melissa M and Gambello, Michael J and Sanchez Russo, Rossana and Dormans, John P and Mulle, Jennifer G},
title = {Musculoskeletal phenotypes in 3q29 deletion syndrome},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
doi = {10.1002/ajmg.a.63384}
}
EUVIMED